Literature DB >> 7945891

The expression and environmental regulation of P450 enzymes in human placenta.

M Pasanen1, O Pelkonen.   

Abstract

The human placenta oxidizes several xenobiotics, although the spectrum of substrates and metabolic activities when compared with the liver appears somewhat restricted. Maternal cigarette smoking or PCB exposure increases the expression of CYP1A1. This induced activity is able to catalyze the activation of benzo(a)pyrene (B(a)P) into DNA-bound products, both in vitro and in vivo. Studies on adult human liver bolster the concept that CYP1A1 and -1A2 are differentially expressed in hepatic and extrahepatic tissues. Studies with cDNA probe or enzyme specific antibodies and substrates for CYP2A, -2B, -2C, -2D, and -2E gene products have yielded negative results. There are only minimal activities that can be found in substantial quantities in placentas without maternal smoking; one example is 7-ethoxycoumarin O-deethylase (ECOD). Aromatase and cholesterol side-chain cleaving P450 mRNAs, proteins, and activities are measurable in human placentas and do not seem to be affected by maternal cigarette smoking.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7945891     DOI: 10.3109/10408449409021606

Source DB:  PubMed          Journal:  Crit Rev Toxicol        ISSN: 1040-8444            Impact factor:   5.635


  17 in total

1.  Sources of Interindividual Variability.

Authors:  Yvonne S Lin; Kenneth E Thummel; Brice D Thompson; Rheem A Totah; Christi W Cho
Journal:  Methods Mol Biol       Date:  2021

2.  Maternal buprenorphine dose, placenta buprenorphine, and metabolite concentrations and neonatal outcomes.

Authors:  Marta Concheiro; Hendreé E Jones; Rolley E Johnson; Robin Choo; Diaa M Shakleya; Marilyn A Huestis
Journal:  Ther Drug Monit       Date:  2010-04       Impact factor: 3.681

Review 3.  The Placental Barrier: the Gate and the Fate in Drug Distribution.

Authors:  Nino Tetro; Sonia Moushaev; Miriam Rubinchik-Stern; Sara Eyal
Journal:  Pharm Res       Date:  2018-02-23       Impact factor: 4.200

Review 4.  The brain-placental axis: Therapeutic and pharmacological relevancy to pregnancy.

Authors:  Susanta K Behura; Pramod Dhakal; Andrew M Kelleher; Ahmed Balboula; Amanda Patterson; Thomas E Spencer
Journal:  Pharmacol Res       Date:  2019-10-07       Impact factor: 7.658

5.  Endocrine disruption in human placenta: expression of the dioxin-inducible enzyme, CYP1A1, is correlated with that of thyroid hormone-regulated genes.

Authors:  Thomas L Wadzinski; Katherine Geromini; Judy McKinley Brewer; Ruby Bansal; Nadia Abdelouahab; Marie-France Langlois; Larissa Takser; R Thomas Zoeller
Journal:  J Clin Endocrinol Metab       Date:  2014-12       Impact factor: 5.958

Review 6.  Drug transfer and metabolism by the human placenta.

Authors:  Michael R Syme; James W Paxton; Jeffrey A Keelan
Journal:  Clin Pharmacokinet       Date:  2004       Impact factor: 6.447

7.  The inhibition of CYP enzymes in mouse and human liver by pilocarpine.

Authors:  T Kimonen; R O Juvonen; E Alhava; M Pasanen
Journal:  Br J Pharmacol       Date:  1995-02       Impact factor: 8.739

8.  Bupropion metabolism by human placenta.

Authors:  Xiaoming Wang; Doaa R Abdelrahman; Olga L Zharikova; Svetlana L Patrikeeva; Gary D V Hankins; Mahmoud S Ahmed; Tatiana N Nanovskaya
Journal:  Biochem Pharmacol       Date:  2010-01-28       Impact factor: 5.858

9.  Selective serotonin reuptake inhibitors and theophylline metabolism in human liver microsomes: potent inhibition by fluvoxamine.

Authors:  B B Rasmussen; J Maënpää; O Pelkonen; S Loft; H E Poulsen; J Lykkesfeldt; K Brøsen
Journal:  Br J Clin Pharmacol       Date:  1995-02       Impact factor: 4.335

10.  Drug Interactions at the Human Placenta: What is the Evidence?

Authors:  Miriam Rubinchik-Stern; Sara Eyal
Journal:  Front Pharmacol       Date:  2012-07-09       Impact factor: 5.810

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.